Mixed General Meeting of 24 June 2026 – Availability of preparatory documents for the meeting

▤ Summary

OSE Immunotherapeutics announced its mixed general meeting for 24 June 2026 in Paris, with a live webcast available for shareholders. The company also published the preliminary notice and made the preparatory documents available on its website and at its headquarters. Shareholders can request the meeting documents by email before the fifth day prior to the meeting, subject to proof of ownership for bearer shares. OSE Immunotherapeutics describes itself as a biotechnology company focused on first-in-class products in immuno-oncology and immuno-inflammation.

▦ Linked Companies